Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...
A GROUNDBREAKING cancer vaccine reversed the disease in nine patients, a study has shown. They remained disease free three ...
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
Originally planned as a two-year study, the trial has been extended by an additional year to collect three-year clinical outcome data The ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
He dismissed this outright. “No, it’s definitely the vaccines,” he insisted, before pivoting to his next pitch: Super Mineral ...
Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for ...
There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its breast cancer vaccine was ...
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...
Union Minister Prataprao Jadhav announced that a cancer vaccine for breast, oral, and cervical cancers in women will be ...